Rosty Raykov - Dec 20, 2021 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Chief Executive Officer, Director
Signature
/s/ Rostislav Raykov, Chief Executive Officer
Stock symbol
FENC
Transactions as of
Dec 20, 2021
Transactions value $
$0
Form type
4
Date filed
12/20/2021, 04:47 PM
Previous filing
Jun 3, 2021
Next filing
Aug 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Option (right to buy) Award $0 +300K $0.00 300K Dec 20, 2021 Common Shares 300K $4.08 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 20, 2021, Rostislav Raykov was granted an incentive stock option to purchase 300,000 shares of the Issuer's common shares pursuant to the Issuer's 2020 Equity Incentive Plan.
F2 Item vests 100% upon FDA approval of PEDMARKTM.